Faculty

Daniel A. Enquobahrie

Professor, Epidemiology
Adjunct Professor, Health Systems and Population Health

206-543-7559
danenq@uw.edu

Education

PhD Epidemiology, University of Washington, 2007
MPH Epidemiology, University of Washington, 2005
MD Medicine (MD), Addis Ababa University, 1996

Contact

206-543-7559
danenq@uw.edu

Box 351619
Department of Epidemiology
Hans Rosling Center for Population Health, 866
Seattle, WA 98195

Bio

Dr. Enquobahrie is Professor in the Department of Epidemiology and Adjunct Professor in the Department of Health Systems and Population Health. He is faculty lead of the MPH-Maternal and Child Health track in the Department of Epidemiology and Associate Director of the Online MPH Program of the School of Public Health.

Research Interests

Dr. Enquobahrie’s research interests span cardiovascular/metabolic, reproductive/perinatal, and genetic/epigenetic epidemiology. His research focuses on (1) pre-pregnancy and early/mid pregnancy risk factors (and associated mechanisms) for pregnancy complications and outcomes, and (2) early life and developmental origins of metabolic and cardiovascular diseases.

Recent Publications (PubMed)

Associations of prenatal exposure to NO(2) and near roadway residence with placental gene expression.
(2023 Jul)
Placenta 138(): 75-82
Hussey MR, Enquobahrie DA, Loftus CT, MacDonald JW, Bammler TK, Paquette AG, Marsit CJ, Szpiro AA, Kaufman JD, LeWinn KZ, Bush NR, Tylavsky F, Zhao Q, Karr CJ, Sathyanarayana S

Assessing Racial Disparities in Access, Use, and Outcomes for Pregnant and Postpartum Veterans and Their Infants in Veterans Health Administration.
(2023 Jul)
J Womens Health (Larchmt) 32(7): 757-766
Katon JG, Bossick AS, Tartaglione EV, Enquobahrie DA, Haeger KO, Johnson AM, Ma EW, Savitz D, Shaw JG, Todd-Stenberg J, Yano EM, Washington DL, Christy AY

Characterization of Xenobiotic and Steroid Disposition Potential of Human Placental Tissue and Cell Lines (BeWo, JEG-3, JAR, and HTR-8/SVneo) by Quantitative Proteomics.
(2023 Aug)
Drug Metab Dispos 51(8): 1053-1063
Kruger L, Lapehn S, Paquette A, Singh DK, MacDonald J, Bammler TK, Enquobahrie DA, Zhao Q, Mozhui K, Sathyanarayana S, Prasad B

Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial.
(2023 Apr)
EClinicalMedicine 58(): 101912
Cherkos AS, LaCourse SM, Enquobahrie DA, Richardson BA, Bradford S, Montepiedra G, Mmbaga BT, Mbengeranwa T, Masheto G, Jean-Phillippe P, Chakhtoura N, Theron G, Weinberg A, Cassim H, Raesi MS, Jean E, Wabwire D, Nematadzira T, Stranix-Chibanda L, Hesseling AC, Aurpibul L, Gupta A, John-Stewart G, IMPAACT P1078 TB APPRISE Study Team

Pregnancy loss and risk of incident CVD within 5 years: Findings from the Women's Health Initiative.
(2023)
Front Cardiovasc Med 10(): 1108286
Wright CE, Enquobahrie DA, Prager S, Painter I, Kooperberg C, Wild RA, Park K, Sealy-Jefferson S, Kernic MA

Show complete publication list